These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 36746639)

  • 1. Boosting Checkpoint Immunotherapy with Biomaterials.
    Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
    ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology.
    Liu Z; Xiang Y; Zheng Y; Kang X
    Front Immunol; 2022; 13():1027124. PubMed ID: 36341334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells.
    Desai N; Hasan U; K J; Mani R; Chauhan M; Basu SM; Giri J
    Acta Biomater; 2023 Apr; 161():1-36. PubMed ID: 36907233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures.
    Li H; Lin WP; Zhang ZN; Sun ZJ
    Acta Biomater; 2023 Dec; 172():1-15. PubMed ID: 37739247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade.
    Choi Y; Seok SH; Yoon HY; Ryu JH; Kwon IC
    Adv Drug Deliv Rev; 2024 Jun; 209():115306. PubMed ID: 38626859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy.
    Chen W; Li C; Jiang X
    Small Methods; 2023 May; 7(5):e2201404. PubMed ID: 36811240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses.
    Chen Q; Chen M; Liu Z
    Chem Soc Rev; 2019 Nov; 48(22):5506-5526. PubMed ID: 31589233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy.
    Wei Q; Zhang L; Zhao N; Cheng Z; Xin H; Ding J
    Front Immunol; 2022; 13():1012927. PubMed ID: 36389700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors.
    Heinhuis KM; Ros W; Kok M; Steeghs N; Beijnen JH; Schellens JHM
    Ann Oncol; 2019 Feb; 30(2):219-235. PubMed ID: 30608567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of nanotechnology in immune checkpoint blockade for cancer treatment.
    Deng H; Zhang Z
    J Control Release; 2018 Nov; 290():28-45. PubMed ID: 30287266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment.
    Luo H; Wang W; Mai J; Yin R; Cai X; Li Q
    Front Immunol; 2023; 14():1267918. PubMed ID: 37881432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming T Cell Exhaustion in Tumor Microenvironment via Immune Checkpoint Modulation with Nano-Delivery Systems for Enhanced Immunotherapy.
    Huang X; Zhang W
    Small Methods; 2024 Aug; 8(8):e2301326. PubMed ID: 38040834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
    Chen Q; Li C; Wang Q
    Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy.
    Gu Y; Zhang Z; Ten Dijke P
    Cell Mol Immunol; 2023 Apr; 20(4):318-340. PubMed ID: 36823234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint-targeted drug conjugates: A promising tool for remodeling tumor immune microenvironment.
    Choi J; Jang H; Choi J; Choi Y; Yang Y; Shim MK; Kim SH
    J Control Release; 2023 Jul; 359():85-96. PubMed ID: 37230294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
    Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
    Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomaterial-assisted photoimmunotherapy for cancer.
    Chen M; Chen Q
    Biomater Sci; 2020 Nov; 8(21):5846-5858. PubMed ID: 33016276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.